HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Jose Manuel Cervera Grau, Speaker at Cancer Conferences
Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Abstract:

The future of cancer management is being reshaped by a convergence of technologies that not only transform diagnosis and treatment, but also the way we understand tumor biology, interact with patients, and design clinical trials (AI, blockchain, supercomputing, and medical devices). Cancer management in the future will be predictive, preventive, personalized and participatory. It will not only be about healing, but also about anticipating , accompanying and transforming. Technology will not replace the oncologist, but it will turn him into an architect of clinical decisions, supported by intelligent systems, molecules designed ad hoc in silico and patients empowered changing  Porter's forces.

Biography:

Jose Manuel Cervera Grau is a specialist in Medical Oncology (18ys), Head of several Research Units from preclinical to clinical setting, In National Research Centers, ITIC, and in General Hospitals with expertise in Clinical Trials, biology, biochemistry and biotechnology (basic and translational research, business development and Clinical Development launching new Drugs of Human Origin in Oncology in big pharma during the last 8 years).Recently developed expertise in AI foundation models and blockchain technologies to be applied in drug discovery programs and early clinical trials creating  complexes projects.

Facebook Twitter XTwitter Youtube
Watsapp